Precancerous Condition Clinical Trials

7 recruitingLast updated: June 17, 2026

There are 7 actively recruiting precancerous condition clinical trials across 5 countries. Studies span Not Applicable. Top locations include Boulogne-Billancourt, France, Clichy, France, Goyang-si, South Korea. Updated daily from ClinicalTrials.gov.


Precancerous Condition Trials at a Glance

7 actively recruiting trials for precancerous condition are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Boulogne-Billancourt, Clichy, and Goyang-si. Lead sponsors running precancerous condition studies include George Zogopoulos, Institut Pasteur, and Changhai Hospital.

Browse precancerous condition trials by phase

Treatments under study

About Precancerous Condition Clinical Trials

Looking for clinical trials for Precancerous Condition? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Precancerous Condition trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Precancerous Condition clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Establishment of Image Database for Early Upper Gastrointestinal Cancer, Precancerous Lesions, and Precancerous Conditions

Upper gastrointestinal cancerUpper Gastrointestinal Precancerous LesionsUpper Gastrointestinal Precancerous Conditions
Changhai Hospital500 enrolled1 locationNCT07462247
Recruiting

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

Colorectal, CancerEsophageal CancerPancreatic Cancer+2 more
Vanderbilt University Medical Center5,000 enrolled2 locationsNCT00899626
Recruiting
Not Applicable

Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)

Stomach NeoplasmsPrecancerous ConditionsGastric Adenoma+1 more
Samsung Medical Center160 enrolled3 locationsNCT07161479
Recruiting

Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers

Esophageal CancerLung CancerHead and Neck Cancer+1 more
University of Colorado, Denver700 enrolled1 locationNCT00900419
Recruiting
Not Applicable

Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer

Gastric CancerGastric LesionGastric Precancerous Condition
Institut Pasteur2,500 enrolled8 locationsNCT05854368
Recruiting

Raman Spectroscopy-Based Deep Learning Model for Early Pan-Cancer Early Diagnosis

Gastric CancersEsophageal CancerCancer Screening+14 more
Second Affiliated Hospital, School of Medicine, Zhejiang University600 enrolled4 locationsNCT06822413
Recruiting

Quebec Pancreas Cancer Study

Pancreatic CancerPancreas CancerHereditary Cancer+8 more
George Zogopoulos2,000 enrolled1 locationNCT04104230